Skip to main content

Table 1 Clinical characteristics of discovery case 1 and 2

From: Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations

Discovery case

Sex

Age at splenectomy

B-Symptoms

Leukemic disease (villous Lymphozytes)

Immunophenotype

Clinical staging at splenectomy

Oncological responsea

1

f

59

yes

no

CD20+++, IgM-, Kappa-, Lambda-, Ki-67 5 %, CD5-, CD3-, Cyclin-D1-, bcl-2++

IV

CR

2

f

59

yes

no

CD20+++, IgM+, Kappa-, Lambda-, Ki-67 15 %, CD5-, CD3-, Cyclin-D1-, bcl-2++

IV

CR

  1. aafter splenectomy